Molina Healthcare Files 8-K

TL;DR

Molina Healthcare just filed an 8-K, check for updates.

AI Summary

Molina Healthcare, Inc. filed an 8-K on November 13, 2024, reporting on events that occurred on November 12, 2024. The filing primarily concerns Regulation FD disclosures and other events, along with financial statements and exhibits. No specific financial figures or new material events were detailed in the provided excerpt.

Why It Matters

This filing indicates Molina Healthcare is providing updates or disclosures to the SEC, which could contain material information for investors.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for disclosures and does not, in this excerpt, detail any negative events or significant financial changes.

Key Players & Entities

• MOLINA HEALTHCARE, INC. (company) — Registrant
• November 13, 2024 (date) — Date of Report
• November 12, 2024 (date) — Date of earliest event reported
• 200 Oceangate, Suite 100, Long Beach, California 90802 (address) — Principal executive offices
• 562-435-3666 (phone_number) — Registrant's telephone number

FAQ

Key Financial Figures

• $0.001 — ge on which registered Common Stock , $0.001 Par Value MOH New York Stock Exchan
• $500 million — subject to market and other conditions, $500 million aggregate principal amount of senior no

Filing Documents

• moh20241112_8k.htm (8-K) — 86KB
• ex_746937.htm (EX-99.1) — 9KB
• mh01.jpg (GRAPHIC) — 6KB
• 0001437749-24-034694.txt ( ) — 245KB
• moh-20241113.xsd (EX-101.SCH) — 3KB
• moh-20241113_def.xml (EX-101.DEF) — 12KB
• moh-20241113_lab.xml (EX-101.LAB) — 15KB
• moh-20241113_pre.xml (EX-101.PRE) — 12KB
• moh20241112_8k_htm.xml (XML) — 3KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. On November 13, 2024, Molina Healthcare, Inc. (the "Company") announced that it intends to privately offer (the "Offering"), subject to market and other conditions, $500 million aggregate principal amount of senior notes due 2033 (the "Notes"). The Notes are to be sold only to persons reasonably believed to be "qualified institutional buyers" pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain persons outside the United States in reliance on Regulation S under the Securities Act. The Notes have not been, and will not be, registered under the Securities Act or the securities laws of any other jurisdiction, and unless so registered, may not be offered or sold in the United States except pursuant to an applicable exemption from the registration requirements of the Securities Act and applicable state laws. This Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to purchase the Notes and shall not constitute an offer, solicitation or sale in any state or jurisdiction where such offer, solicitation or sale is prohibited. Uses and Definitions of Non-GAAP Financial Measures The financial data provided to potential investors in connection with the Offering includes non-GAAP financial measures, including EBITDA and Adjusted EBITDA (collectively, the "Non-GAAP Financial Measures"). The Non-GAAP Financial Measures are supplemental measures of the Company's performance that are not required by, or presented in accordance with, generally accepted accounting principles in the U.S. ("GAAP"). The Company believes that the Non-GAAP Financial Measures are useful supplemental measures to investors in comparing its performance to the performance of other public companies in the healthcare industry. The Company defines EBITDA as net income adjusted for interest, taxes, depreciation and amortization. The Company defines Adjusted EBITDA as EBITDA adju

01. Other Events

Item 8.01. Other Events . As disclosed above in Item 7.01, on November 13, 2024, the Company issued a press release announcing the Offering of the Notes. The full text of the press release is attached as Exhibit 99.1.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 99.1 Press release of Molina Healthcare, Inc. issued November 13, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MOLINA HEALTHCARE, INC. Date: November 13, 2024 By: /s/ Jeff D. Barlow Jeff D. Barlow, Chief Legal Officer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR